EDAP Secures EUR36 Million Credit Facility to Accelerate Growth of Focal One Robotic HIFU Platform

EDAP TMS SA, a global leader in robotic, energy-based therapeutic technologies, has entered into a EUR36 million multi-tranche credit facility with the European Investment Bank (EIB) to support the continued global expansion of its Focal One Robotic High-Intensity Focused Ultrasound (HIFU) platform. The funds will accelerate the development of new clinical indications for the Company's innovative HIFU technology and further expand the reach of Focal One Robotic HIFU to meet the growing global patient demand for effective non-invasive treatment options for both cancer and benign conditions.

Key Takeaways:

  • EDAP TMS SA has secured a EUR36 million credit facility from the European Investment Bank (EIB) to accelerate the growth of its Focal One Robotic HIFU platform.
  • The credit facility will be disbursed in three tranches: Tranche A for EUR 11 million, Tranche B for EUR 12 million, and Tranche C for EUR 13 million, each with a different interest rate.
  • EDAP expects to draw the first tranche of EUR11 million under the credit facility in the fourth quarter of 2025.
  • The company will issue warrants to the EIB specific to each tranche, providing the right to subscribe to the most preferential class of Company shares.
  • The collaboration with the EIB underscores EDAP's ongoing commitment to driving innovation in urological, gynecological, and therapy-based care through the development and commercialization of cutting-edge robotic HIFU technologies.
  • The Focal One Robotic HIFU platform has the potential to expand to multiple indications beyond prostate cancer, including benign conditions.
  • EDAP's innovative HIFU technology has the potential to meet the growing global patient demand for effective non-invasive treatment options for both cancer and benign conditions.

Statistics:

  • Total credit facility amount: EUR 36 million
  • Interest rates for each tranche: Tranche A - 8%, Tranche B - 7%, Tranche C - 6%
  • Tranche A disbursement date: Fourth quarter of 2025
  • Maturity date for each tranche: 5 years from the date of disbursement
  • Total number of warrants to be issued to the EIB: Specific to each tranche

Sources:

  • [edap.com](http://edap.com) - EDAP TMS SA website
  • [eib.org](http://eib.org) - European Investment Bank (EIB) website
  • Securities and Exchange Commission filings, specifically EDAP TMS SA's Annual Report on Form 20-F